The latest from Orcosa

Andy Drechsler joins Orcosa as Chief Financial Officer

An experienced life sciences finance leader joins the team to support Orcosa’s development and growth.

European patent strengthens protection for ORC-144

European Patent No. 4 243 797 adds to Orcosa’s intellectual property portfolio supporting its investigational CBD tablet for acute pain.

Orcosa receives U.S. patent for packaging designed around RITe™ tablets

U.S. Patent No. 12,383,494 recognizes packaging technology designed to preserve tablet integrity and protect sensitive formulations.

Vincent Mileto named to NJBIZ’s 2025 People to Watch in Health Care

NJBIZ recognizes Orcosa’s Co-Founder and Chief Operating Officer for his work advancing a new approach to taking medicine.

Kevin Kaplan, MD, appointed Chief Medical Officer

An orthopedic surgeon and sports medicine leader brings a patient-care perspective to Orcosa’s clinical development.

One-year study adds reassuring follow-up data for ORC-144

Follow-up of the shoulder surgery trial found no significant differences in pain, satisfaction, or patient-reported shoulder outcomes between the ORC-144 and placebo groups at one year.

Edward Sturchio and Robert Radie join Orcosa’s Board of Directors

Two independent directors add complementary experience in pharmaceutical leadership, development, and corporate strategy.

Orcosa secures U.S. patent supporting ORC-144 development

U.S. Patent No. 11,672,761 marks an important milestone for Orcosa’s proprietary CBD tablet and its development for acute pain.

ORC-144 research presented at the SECEC-ESSSE Congress

Landmark ORC-144 clinical trial results published in AJSM

A randomized, double-blind study at NYU Langone and Baptist Health/Jacksonville Orthopaedic Institute reported less pain on the first day after shoulder surgery and greater satisfaction with pain control on days one and two.

ORC-144 research presented at the AOSSM Annual Meeting

Former FDA Commissioner Andrew C. von Eschenbach, MD, joins Orcosa as Senior Advisor

Experience in medicine, research, and public health adds depth to Orcosa’s advisory team.

ORC-144 research presented at the AAOS Annual Meeting